Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKK vs Bupivacaine for CIED Pocket Pain
NCT05575999Phase 1Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of bupivacaine, ketorolac and ketamine in postoperative pain (2 arms). Primary endpoints: Pain Intensity at 1 week, Comfort at 1 week and 1 more. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
bupivacaineketorolacketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05575999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05575999.